PillPack (Amazon Pharmacy) vs Hims & Hers

Side-by-side comparison of AI visibility scores, market position, and capabilities

Hims & Hers leads in AI visibility (86 vs 58)
PillPack (Amazon Pharmacy) logo

PillPack (Amazon Pharmacy)

ChallengerHealthcare

Online Pharmacy

Amazon's pharmacy combining PillPack multi-medication pre-sorting with Prime prescription delivery; disrupting CVS and Walgreens with price transparency and same-day delivery in growing cities.

AI VisibilityBeta
Overall Score
C58
Category Rank
#144 of 596
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
64
Perplexity
58
Gemini
53

About

PillPack (now Amazon Pharmacy) is Amazon's full-service online pharmacy providing prescription delivery, medication management, and pharmacy services to US customers — originally founded as PillPack in 2013 by TJ Parker and Elliott Cohen to solve medication adherence for patients on multiple prescriptions, then acquired by Amazon in 2018 for $1 billion. Amazon has since rebranded the full-service pharmacy to Amazon Pharmacy while maintaining the PillPack brand for the multi-medication pre-sorting service for customers taking 5+ daily medications.\n\nPillPack's distinctive original service pre-sorts medications by dose and time (individual packets labeled "Monday 8AM: Take these 3 pills"), eliminating the confusion of managing multiple prescription bottles for patients with complex medication regimens. This packaging format particularly serves elderly patients and chronic disease patients taking 5-15 medications daily. Amazon Pharmacy (the broader service) provides standard prescription delivery with Prime shipping, price transparency through Amazon's prescription discount program, and pharmacist consultations.\n\nIn 2025, Amazon Pharmacy operates as a significant disruptor in the $350 billion US prescription market, competing with CVS Health (the largest pharmacy chain), Walgreens, Express Scripts (mail-order PBM pharmacy), and new pharmacy entrants like Ro, Alto Pharmacy, and Capsule. Amazon's advantages are its logistics infrastructure (Prime 2-day/same-day delivery), price comparison transparency, and consumer trust for e-commerce transactions. The 2025 strategy focuses on expanding same-day prescription delivery in more cities, growing specialty pharmacy capabilities for high-cost biologic medications, and integrating pharmacy with Amazon's broader health ecosystem (One Medical primary care, Amazon HealthLake health records).

Full profile
Hims & Hers logo

Hims & Hers

EmergingHealthcare

Telehealth Pharmacy

Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.

AI VisibilityBeta
Overall Score
A86
Category Rank
#8 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
92
Gemini
83

About

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.

Full profile

AI Visibility Head-to-Head

58
Overall Score
86
#144
Category Rank
#8
70
AI Consensus
79
stable
Trend
stable
64
ChatGPT
88
58
Perplexity
92
53
Gemini
83
63
Claude
90
54
Grok
89

Key Details

Category
Online Pharmacy
Telehealth Pharmacy
Tier
Challenger
Emerging
Entity Type
product
brand

Capabilities & Ecosystem

Capabilities

Only PillPack (Amazon Pharmacy)
Online Pharmacy
Only Hims & Hers
Telehealth Pharmacy
PillPack (Amazon Pharmacy) is classified as product (part of Amazon).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.